US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 1.180
- -0.060-4.87%
Trading Sep 11 13:53 ET
11.52MMarket Cap-581P/E (TTM)
1.290High1.050Low1.74MVolume1.050Open1.240Pre Close2.00MTurnover19.44%Turnover RatioLossP/E (Static)9.77MShares13.55852wk High-3.33P/B10.55MFloat Cap0.82652wk Low--Dividend TTM8.95MShs Float13.558Historical High--Div YieldTTM19.36%Amplitude0.826Historical Low1.152Avg Price1Lot Size
About Silexion Therapeutics Company
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.
Company Profile
SymbolSLXN
Company NameSilexion Therapeutics
Listing DateApr 9, 2021
CEOMr. Ilan Hadar
MarketNASDAQ
Address2 HaMa'ayan Street
CityModi’in
ProvinceJerusalem
CountryIsrael
Zip Code7177871
Phone972-8-628-6005
Websitehttps://www.silexion.com
Company Executives
- Name
- Position
- Salary
- Ilan Hadar
- Chairman of the Board and Prospective Chief Executive Officer
- 253.61K
- Dr. Mitchell Shirvan
- Chief Scientific and Development Officer
- 206.80K
- Mirit Horenshtein Hadar
- Executive Vice President, Finance Affairs and Prospective Chief Financial Officer
- 26.24K
- Ruth Alon
- Independent Director
- --
- Ilan Levin
- Independent Director
- --
- Dror J. Abramov
- Independent Director
- --
- Avner Lushi
- Independent Director
- --
- Shlomo Noy
- Independent Director
- --
- Ilan Shiloah
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
